Sorry Dew , I missed this post . BMY/ MYOK data is looking better by the day https://www.biospace.com/article/gearing-up-for-fda-decision-bms-presents-robust-mavacamten-data-in-hcm/ and CYTK's data disappoints . No position in either Kiwi